本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Reata制药

172.36
+0.0000
成交量:- -
成交额:- -
市值:65.66亿
市盈率:-72.69
高:172.36
开:172.36
低:172.36
收:172.36
数据加载中...
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities